PROVIDENCE, R.I. (Legal Newsline) - Rhode Island Attorney General Peter Kilmartin announced on Monday that his Medicaid Fraud and Control Unit recovered more than $8.1 million for the state's Medicaid budget in 2013.
Last year, the MFCU entered into 16 settlement agreements with major pharmaceutical companies that allegedly overbilled the state for drugs and/or engaged in off-label billing. The settlements resulted in the recovery of $6.8 million in funds returned to the Medicaid budget. The MFCU also recovered $1,276,530 in civil penalties from physician practices for alleged coding and overbilling errors and $81,365 from individuals convicted of patient abuse or Medicaid fraud.
"Medicaid is one of Rhode Island's most expensive programs and cannot afford to be plagued with fraud, waste and abuse," Kilmartin said. "From big pharma looking to pocket tens of millions of dollars in profits through the off-label marketing of drugs to individual caregivers who defraud the system a few hundred dollars at a time, each must be held accountable."
In November, the MFCU recovered $5.6 million as part of a multi-state and federal settlement with Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc. One of the unit's largest settlements with an individual physician was a $244,923 settlement with Hafeez Kahn, a former Rhode Island physician.
The MFCU enforces laws that pertain to fraud in the Rhode Island Medicaid program and prosecutes cases of neglect, abuse or mistreatment of patients in all state healthcare facilities. The MFCU also works with federal and state authorities to look into pharmaceutical companies who defraud and overbill the state's Medicaid program.
- Calif. jury awards $4.5 million to plaintiff in case against hip implant maker
- MDL panel decides to consolidate Lumber Liquidators class actions
- MDL established for Anthem data breach class actions
- One class action against AAMCO dismissed, under mediation while another remains
- La. AG's antitrust suit against Pfizer relying on private attorneys, campaign donors
- N.M. AG defends decision to pursue nursing service providers, use outside counsel
- N.J. lawmakers argue role of AG is ‘important’ one, needs to be elected
- Software company claims Microsoft continues to infringe on ‘out-of-band’ patents
- Miss. SC denies utility’s request for rehearing on refund ruling
- Goodlatte’s Innovation Act passes House committee, with some tweaks